Keywords: ساختار مبتنی بر طراحی دارو; Quinazolinones; Molluscicidal and cercaricidal agents; Structure based drug design; Scaffold hopping; Intramolecular hydrogen bond;
مقالات ISI ساختار مبتنی بر طراحی دارو (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ساختار مبتنی بر طراحی دارو; Interleukin receptor-associated kinases; Inflammation; Drug discovery; SAR; Structure based drug design
Keywords: ساختار مبتنی بر طراحی دارو; Structure based drug design; ABL; Aurora; Drug repurposing; Crystal structure; Cheminformatics
Keywords: ساختار مبتنی بر طراحی دارو; Cholera toxin; ARF6 (ADP Ribosylation Factor 6); Computational solvent mapping; Ligandability; Structure based drug design; Virtual screening
Keywords: ساختار مبتنی بر طراحی دارو; Structure based drug design; Antibacterial agents;
Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen
Keywords: ساختار مبتنی بر طراحی دارو; NAMPT; In silico screen; Structure based drug design; Cyclopropane; Nicotinamide phosphoribosyltransferase;
Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Factor IXa inhibitor; Anticoagulant; Aminobenzisoxazole; Azabicyclic ring; Structure based drug design;
Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease
Keywords: ساختار مبتنی بر طراحی دارو; DJ-1; Parkinson's disease; Protein structure; Oxidative stress; Molecular dynamics; Structure based drug design;
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential
Keywords: ساختار مبتنی بر طراحی دارو; ADME; absorption, distribution, metabolism, and excretion; AML; acute myelogenous leukemia; AUC; area under the blood concentration time curve; b.i.d.; twice a day; CDK; Cyclin-dependent kinase; CLtotal; clearance; Cmax; maximum drug concentration; CRC; c
Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2)
Keywords: ساختار مبتنی بر طراحی دارو; ERK1/2 kinase inhibitor; Indazole amide; Structure based drug design;
Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents
Keywords: ساختار مبتنی بر طراحی دارو; Leishmaniasis; Structure based drug design; Chalcones; Dihydropyrimidine; Docking; Rigidification
Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase
Keywords: ساختار مبتنی بر طراحی دارو; ERK2 kinase; Fragment lead; Structure based drug design; Extraction ratio; ATP binding cleft
Rapid development of two factor IXa inhibitors from hit to lead
Keywords: ساختار مبتنی بر طراحی دارو; Factor IXa; Hit-to-lead; Structure based drug design; Parallel synthesis; Anticoagulant
Development of a novel class of potent and selective FIXa inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Benzimidazole; FIXa inhibitor; TGA; Structure based drug design;
Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase
Keywords: ساختار مبتنی بر طراحی دارو; ERK2 kinase; Structure based drug design; Extraction ratio; ATP binding cleft; Lower-hinge lysine
Development of a novel tricyclic class of potent and selective FIXa inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Benzimidazole; Quninazolinone; FIXa inhibitor; TGA; Structure based drug design;
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Pim kinases; Kinase inhibitor; Screening; Fragment based screen; Structure based drug design; Lead optimization;
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2
Keywords: ساختار مبتنی بر طراحی دارو; Erk2 kinase inhibitors; Mek resistance; Structure based drug design
Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines
Keywords: ساختار مبتنی بر طراحی دارو; Kinase inhibitors; Janus kinase; JAK; Structure based drug design; Scaffold hopping; Intramolecular hydrogen bond;
GPCR structures in drug design, emerging opportunities with new structures
Keywords: ساختار مبتنی بر طراحی دارو; GPCR structure; Structure based drug design; Ligand bias;
Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; JAK; JAK3; Janus kinase; Kinase inhibitors; Structure based drug design;
Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Hepatitis C virus; NS5B polymerase; Antiviral; Non-nucleoside inhibitor; Structure based drug design; Parallel synthesis;
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: Optimization studies and demonstration of in vivo efficacy
Keywords: ساختار مبتنی بر طراحی دارو; Phosphodiesterase 2 (PDE2) inhibitors; Structure based drug design; Osteoarthritis (OA) pain
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design
Keywords: ساختار مبتنی بر طراحی دارو; Pim kinases; Kinase inhibitor; Structure based drug design; High throughput screening; Lead optimization
A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity
Keywords: ساختار مبتنی بر طراحی دارو; Serine protease; Asthma; COPD; hERG; Tryptase; Inhibitor; Molecular modeling; Structure based drug design; X-ray; Benzylamine;
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase
Keywords: ساختار مبتنی بر طراحی دارو; B-Raf; Kinase; Drug discovery; Pyridopyrimidin-7-one; Structure based drug design
Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC
Keywords: ساختار مبتنی بر طراحی دارو; LpxC; Antibacterial; Gram negative; Structure based drug design; Hydroxamic acid; Pseudomonas aeruginosa; LipE; Lipophilic efficiency; Computer aided drug design
A new method for induced fit docking (genius) and its application to virtual screening of novel HCV NS3-4A protease inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; HCV; NS 3-4A protease; Structure based drug design; Ligand docking; Virtual screening;
Insights into protein kinase regulation and inhibition by large scale structural comparison
Keywords: ساختار مبتنی بر طراحی دارو; Protein kinase; Structure based drug design; X-ray crystallography; Atypical kinase; Kinase regulation;
New design platform for malonyl-CoA-acyl carrier protein transacylase
Keywords: ساختار مبتنی بر طراحی دارو; MCAT; malonyl-CoA-acyl carrier protein transacylase; CoA; coenzyme A; ACP; acyl carrier protein; Fatty-acid biosynthesis; FabD; MCAT; Antibacterial; Structure based drug design;
Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
Keywords: ساختار مبتنی بر طراحی دارو; Renin; Aspartyl protease; Antihypertensive; Structure based drug design
The importance of CH/π hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase
Keywords: ساختار مبتنی بر طراحی دارو; CH/π hydrogen bond; Weak hydrogen bond; An ab initio fragment molecular orbital method; Weak molecular interaction; Leukocyte-specific protein tyrosine (LCK) kinase; Rational drug design; Structure based drug design; Kinase inhibitor
Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Renin inhibitor; Hypertension; 2,4-Diaminopyrimidine; Structure based drug design; Renin–angiotensin system; RAS; Conformational overlap; Scaffold hopping
Structure–activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors
Keywords: ساختار مبتنی بر طراحی دارو; Pantothenate kinase; Pantothenamide; Fatty acid synthase; Structure based drug design; Coenzyme A
Crystal structures of human HSP90α-complexed with dihydroxyphenylpyrazoles
Keywords: ساختار مبتنی بر طراحی دارو; Hsp90; Pyrazole; Dihydroxyphenylpyrazole; Co-crystal; 3D-structure; Structure based drug design;